Bone Health History in Breast Cancer Patients on Aromatase Inhibitors

A cross-sectional study was performed to assess bone health history among aromatase inhibitor (AI) users before breast cancer (BC) diagnosis, which may impact fracture risk after AI therapy and choice of initial hormonal therapy. A total of 2,157 invasive BC patients initially treated with an AI wer...

Descripción completa

Detalles Bibliográficos
Autores principales: Kwan, Marilyn L., Lo, Joan C., Tang, Li, Laurent, Cecile A., Roh, Janise M., Chandra, Malini, Hahn, Theresa E., Hong, Chi-Chen, Sucheston-Campbell, Lara, Hershman, Dawn L., Quesenberry, Charles P., Ambrosone, Christine B., Kushi, Lawrence H., Yao, Song
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4213031/
https://www.ncbi.nlm.nih.gov/pubmed/25354083
http://dx.doi.org/10.1371/journal.pone.0111477

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4213031/
https://www.ncbi.nlm.nih.gov/pubmed/25354083
http://dx.doi.org/10.1371/journal.pone.0111477

Ejemplares similares